Utilizing investors on and off your Board
Written by
Peter Kolchinsky
Managing Partner
As investors, our team has experience with all kinds of companies. Successful ones that initially seemed poised to fail, failures that once looked promising, and everything in between. That’s not just at RA Capital either; most institutional investors can claim the same.
So if you have investors on your board, you should consider the types of expertise, perspectives, and experiences they bring to your company — and how you can leverage those as you navigate through various challenges. Hear from our cast of biotech executives and board members on Gateway as they discuss how they utilize the investors on their boards.
- Peter Kolchinsky, PhD — Managing Partner, RA Capital Management
- Michael Bailey, MBA — President & CEO, AVEO Oncology
- Jayson Dallas, MD — Executive Chair, Rivus Pharmaceuticals
- Dan Welch, MBA — Former CEO, Current Board Chair & Advisor
- Paul Hastings — President & CEO, Nkarta Therapeutics
- Ted Love, MD — President & CEO, Global Blood Therapeutics